Artivion, Inc.

NYSE:AORT Stock Report

Mkt Cap: US$631.5m

Artivion Past Performance

Past criteria checks 0/6

Artivion's earnings have been declining at an average annual rate of -48.5%, while the Medical Equipment industry saw earnings growing at 10% annually. Revenues have been growing at an average rate of 6% per year.

Key information

-48.5%

Earnings growth rate

-46.5%

EPS growth rate

Medical Equipment Industry Growth10.0%
Revenue growth rate6.0%
Return on equity-10.5%
Net Margin-9.1%
Last Earnings Update31 Mar 2023

Recent past performance updates

Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher

May 10
Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher

Recent updates

Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher

May 10
Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher

Artivion (NYSE:AORT) Has A Somewhat Strained Balance Sheet

Mar 09
Artivion (NYSE:AORT) Has A Somewhat Strained Balance Sheet

Artivion Non-GAAP EPS of $0.10 beats by $0.12, revenue of $79.4M misses by $0.77M

Feb 16

Artivion: PROACT Xa Overhang Remains Well In Situ, Reaffirm Hold

Dec 18

Artivion (NYSE:AORT) Is Making Moderate Use Of Debt

Sep 29
Artivion (NYSE:AORT) Is Making Moderate Use Of Debt

Artivion: Stopping PROACT Xa Trial Removes Long-Term Growth Driver

Sep 27

Artivion Non-GAAP EPS of -$0.03 misses by $0.06, revenue of $80.34M beats by $3.07M

Aug 04

Is Artivion (NYSE:AORT) Using Too Much Debt?

Jun 27
Is Artivion (NYSE:AORT) Using Too Much Debt?

Is Artivion (NYSE:AORT) Using Too Much Debt?

Mar 25
Is Artivion (NYSE:AORT) Using Too Much Debt?

CryoLife (NYSE:CRY) Has A Somewhat Strained Balance Sheet

Dec 08
CryoLife (NYSE:CRY) Has A Somewhat Strained Balance Sheet

CryoLife, Inc. (NYSE:CRY) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 01
CryoLife, Inc. (NYSE:CRY) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

CryoLife (NYSE:CRY) Takes On Some Risk With Its Use Of Debt

Jul 30
CryoLife (NYSE:CRY) Takes On Some Risk With Its Use Of Debt

Cryolife (CRY) Investor Presentation - Slideshow

May 28

CryoLife (NYSE:CRY) Seems To Be Using A Lot Of Debt

Feb 05
CryoLife (NYSE:CRY) Seems To Be Using A Lot Of Debt

CryoLife: Upside Potential Via Operating Leverage But Liquidity Pressures Loom

Dec 16

Earnings and Revenue History

Quality Earnings: AORT is currently unprofitable.

Growing Profit Margin: AORT is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: AORT is unprofitable, and losses have increased over the past 5 years at a rate of 48.5% per year.

Accelerating Growth: Unable to compare AORT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AORT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.5%).

Return on Equity

High ROE: AORT has a negative Return on Equity (-10.48%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies